1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year

Eli Lilly (NYSE: LLY) stock recently reached a big milestone, surpassing the level of $1,000. This wasn't too much of a surprise as the shares have marched higher in recent years thanks to the company's strengths in a high-growth area: the weight loss drug market. Demand for these drugs has been so strong that they even spent last year on the U.S. Food and Drug Administration's shortage list.Though Lilly stock has climbed more than 100% over the past three years, I think it still has room to run in both the short term and the long term. Let's check out one big reason to buy Eli Lilly shares hand over fist before the new year.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool